These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7056276)

  • 1. Protein binding of piretanide in normal and uraemic serum.
    Elliott HL; Ansari AF; Campbell BC; Lawrence JR
    Eur J Clin Pharmacol; 1982; 21(4):311-3. PubMed ID: 7056276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid: binding levels of urate ions in normal and uraemic plasma, and in human serum albumin.
    Farrell PC; Ward RA; Hone PW
    Biochem Pharmacol; 1975 Oct; 24(20):1885-7. PubMed ID: 1191338
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of several loop diuretics to serum albumin and human serum from patients with renal failure and liver disease.
    Goto S; Yoshitomi H; Miyamoto A; Inoue K; Nakano M
    J Pharmacobiodyn; 1980 Dec; 3(12):667-76. PubMed ID: 7277182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on paracetamol binding to serum proteins.
    Milligan TP; Morris HC; Hammond PM; Price CP
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():492-6. PubMed ID: 7832576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients.
    Ehrnebo M; Odar-Cederlöf I
    Eur J Clin Pharmacol; 1975 Aug; 8(6):445-53. PubMed ID: 1233247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease.
    Goto S; Yoshitomi H; Miyamoto A; Yamada H; Fujii S; Nakayama T; Fujiwara K
    J Pharmacobiodyn; 1981 Nov; 4(11):865-73. PubMed ID: 7328487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pressure ultrafiltration method for serum free drug determination. Comparison with equilibrium dialysis using normal and uraemic sera.
    Tiula E
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):51-5. PubMed ID: 6717171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the loop diuretic piretanide in renal failure.
    Walter U; Röckel A; Lahn W; Heidland A; Heptner W
    Eur J Clin Pharmacol; 1985; 29(3):337-43. PubMed ID: 4076330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
    Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
    J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.
    Mingrone G; De Smet R; Greco AV; Bertuzzi A; Gandolfi A; Ringoir S; Vanholder R
    Clin Chim Acta; 1997 Apr; 260(1):27-34. PubMed ID: 9101098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of tienilic acid (Diflurex) to human serum albumin and to plasma of normal subjects and uraemic patients.
    Prandota J; Tillement JP; d'Athis P; Drüeke T; Digiulio S
    Eur J Drug Metab Pharmacokinet; 1980; 5(2):99-106. PubMed ID: 7398682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].
    Heuer LJ; Machnik H; Studt J; Fink R
    Arzneimittelforschung; 1983; 33(9):1318-21. PubMed ID: 6685516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro protein binding of propafenone in normal and uraemic human sera.
    Chan GL; Axelson JE; Price JD; McErlane KM; Kerr CR
    Eur J Clin Pharmacol; 1989; 36(5):495-9. PubMed ID: 2753068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug binding defect of uraemic plasma: unlikely involvement of carbamoylated albumin.
    Clegg LS; Lindup WE
    Biochem Pharmacol; 1982 Sep; 31(17):2791-4. PubMed ID: 7138574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis.
    Dasgupta A; Peng Y
    Life Sci; 1991; 49(22):1603-9. PubMed ID: 1943464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A; Sjöholm I; Borgå O; Odar-Cederlöf I
    Biochem Pharmacol; 1979 Apr; 28(7):1037-42. PubMed ID: 444260
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.